title: Role of serotonergic gene polymorphisms on response to transcranial magnetic stimulation in depression.
abstract: Transcranial magnetic stimulation (TMS) has been extensively studied as a treatment for Major Depression. However, no data are available about the role of genetic variables on the response to this treatment. We analysed the role of two polymorphisms that influence the response to antidepressants: the polymorphisms of the serotonin transporter promoter region (SERTPR) and of the 5-HT(1A) serotonergic receptor promoter region (-1019C/G). Ninety-nine patients from two double-blind, randomised, sham-controlled TMS trials were enrolled. There was a significant influence (p=0.016) of the SERTPR polymorphism on treatment outcome, without differences between active and sham stimulation. Conversely, there was a significant (p=0.014) interaction between 5-HT(1A) genotype and type of stimulation: C/C patients showed a higher difference between active and sham stimulation, indicating that these patients benefited more by TMS than C/G and G/G subjects. Our sample has not the power to control for the possible influence of different medications on these results.
authors.affiliation: Department of Psychiatry, School of Medicine, Vita-Salute University San Raffaele, Via Stamira D'Ancona 20, Milan 20127, Italy. zanardi.raffaella@hsr.it
authors.forename: Raffaella
authors.initials: R
authors.lastname: Zanardi
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Magri
authors.forename: David
authors.initials: D
authors.lastname: Rossini
authors.forename: Alessia
authors.initials: A
authors.lastname: Malaguti
authors.forename: Silvia
authors.initials: S
authors.lastname: Giordani
authors.forename: Cristina
authors.initials: C
authors.lastname: Lorenzi
authors.forename: Adele
authors.initials: A
authors.lastname: Pirovano
authors.forename: Enrico
authors.initials: E
authors.lastname: Smeraldi
authors.forename: Adelio
authors.initials: A
authors.lastname: Lucca
mesh_terms: D000328:Adult; D000368:Aged; D000928:Antidepressive Agents / Q000627:therapeutic use*; D016009:Chi-Square Distribution; D004252:DNA Mutational Analysis; D003863:Depression / Q000235:genetics* / Q000628:therapy*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D011110:Polymorphism, Genetic; D011401:Promoter Regions, Genetic; D044282:Receptor, Serotonin, 5-HT1A / Q000235:genetics*; D050486:Serotonin Plasma Membrane Transport Proteins / Q000235:genetics*; D050781:Transcranial Magnetic Stimulation; D016896:Treatment Outcome
chemical_list: D000928:Antidepressive Agents; D050486:Serotonin Plasma Membrane Transport Proteins; D044282:Receptor, Serotonin, 5-HT1A